Home  |  Contact

UniProtKB/Swiss-Prot P07954: Variant p.Asn107Thr

Fumarate hydratase, mitochondrial
Gene: FH
Variant information

Variant position:  107
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Asparagine (N) to Threonine (T) at position 107 (N107T, p.Asn107Thr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and polar.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In HLRCC.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  107
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  510
The length of the canonical sequence.

Location on the sequence:   RMPTPVIKAFGILKRAAAEV  N QDYGLDPKIANAIMKAADEV
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RMPTPVIKAFGILKRAAAEVNQDY-GLDPKIANAIMKAADEV

Mouse                         RMPIPVIQAFGILKRAAAEVNQEY-GLDPKIASAIMKAADE

Rat                           RMPIPVIKAFGILKRAAAEVNQEY-GLDPKIASAIMKAADE

Pig                           RMPIPVIKAFGILKRAAAEVNQDY-GLDPKIANAIMKAADE

Zebrafish                     RMPIQVIRAFGILKKAAAEVNKDY-GLDPKIADAIMKAADE

Caenorhabditis elegans        RMPIPVIHAFGILKKAAALVNTEF-GLDKKLADAISQAADE

Slime mold                    KMPLMVVRSFGILKRCAAIVNKKY-GLDATIADNIAKAATE

Baker's yeast                 RMPLPLVHAFGVLKKSAAIVNESLGGLDPKISKAIQQAADE

Fission yeast                 RLPLPLVRAFGVLKRAAASVNREF-GLDPKLADAIEQAAQE

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 45 – 510 Fumarate hydratase, mitochondrial
Modified residue 90 – 90 Phosphothreonine
Modified residue 94 – 94 N6-acetyllysine
Modified residue 115 – 115 N6-acetyllysine; alternate
Modified residue 115 – 115 N6-succinyllysine; alternate
Modified residue 122 – 122 N6-acetyllysine; alternate
Modified residue 122 – 122 N6-succinyllysine; alternate
Helix 90 – 107


Literature citations

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Tomlinson I.P.M.; Alam N.A.; Rowan A.J.; Barclay E.; Jaeger E.E.M.; Kelsell D.; Leigh I.; Gorman P.; Lamlum H.; Rahman S.; Roylance R.R.; Olpin S.; Bevan S.; Barker K.; Hearle N.; Houlston R.S.; Kiuru M.; Lehtonen R.; Karhu A.; Vilkki S.; Laiho P.; Eklund C.; Vierimaa O.; Aittomaeki K.; Hietala M.; Sistonen P.; Paetau A.; Salovaara R.; Herva R.; Launonen V.; Aaltonen L.A.;
Nat. Genet. 30:406-410(2002)
Cited for: VARIANTS HLRCC THR-107; PRO-117; ARG-180; ARG-185; ARG-230; HIS-233; VAL-282 AND ARG-328;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.